„Santara“ Valley experience in new health technologies

Vladas Algirdas Bumelis

1

„Santara“ Valley • Integrated scientific and business center was established in

2008. It will be finished by the end of 2013.

• Main objectives are: biotechnology, molecular medicine, innovative medical technologies, ecosystem and information, communication technologies.

• Goal is: to reach global level in biotechnology, bio pharmacy and IT sectors.

• It is planed to create 1200 new work places.

• 5 times growth in biotechnology and bio pharmacy generated GDP (approx. up to 0,5% of GDP per year).

2

„Santara“ Valley Development

3

2009 2011-2012

2013-2015

„Santara“ Valley • The facilities:

– Hospital and laboratories of 5 research institutes

– 2 GMP-compliant pharmaceuticals plants

– 4 high-tech R&D facilities

- Healthcare / Hospital

- Public research institutions

- Private R&D and manufacturing centers

- Business incubators / STP

4

Public sector:

• Institute of Innovative Medicine,

• Institute of Biochemistry,

• Institute of Mathematics and Informatics,

• Environmental research center,

• Institute of Oncology

The business:

• Biotechpharma R&D and Production plant,

• TEVA biotech plant,

• MOOG Medical Devices plant,

• Valentis Pharma plant,

• Baltic Solar Energy plant

• Valleys’ monitoring group is composed from Lithuanian and foreign experts.

• 100 mln. EUR were invested in “Santara” valley

• Several R&D sectors are going to be developed:

• biotechnology,

• bio pharmacy,

• innovative medicine technologies,

• molecular medicine,

• solar batteries and IT technologies

5

„Santara“ Valley

Biotechnologies • Sicor Biotech and Biotechpharma both biopharmaceuticals developers and

producers are members of „Santara“ Valley

• New biopharmaceutical for hepatitis C is being developed and produced in Biotechpharma

• Monoclonal antibodies used for different purposes are in stage of development

• Bio similars are developed and produced. Sicor biotech has developed and is producing GCSF, which has passed EMA and FDA audits

6

Innovative Medicine center • New research and development center for

innovative medicine and biopharmasy is being built in „Santara“ Valley.

• 7000 sq. m. for different purposes laboratories and “Open” laboratories.

• Laboratories for research:

• immunotechnology,

• biopharmaceutical processes,

• biomedical information and visualization algorithms,

• innovative medical technologies,

• bio models,

• stem cells.

7

Medicine • Vilnius University hospital Santariškių Klinikos is a hospital constantly

investing in innovative medicine technologies

• Development of :

• Medical imaging

• Health system online – E-HEALTH

• Molecular diagnostics

• Personalised medicine

• Minimal invasion technologies

• Clinical research infrastructure

8

Medical devices

• MOOG Medical Devices a member of „Santara“ valley

• Development of medical technologies

• Research for new technologies

• Producing innovative injection medical devices

9

Results • “Santara” valley is developing according to the program:

– there are well established scientific centers,

– established new biotechnology company “Biotechpharma”,

– MOOG medical devices invested in their research and development center,

– Vilniaus Universiteto Sanatarškių klinikos are establishing new centers and providing new innovative medicine services.

10

Results • Innovative product development and scientific research is being promoted

by combining private and public entities.

• In 2011 0,3% of GDP was generated by biotech and bio pharmacy companies – 3 times increase since 2009.

• Global investors identify “Santara” Valley as a Innovation Hub of Northern Europe.

• Global companies are investing in infrastructure or outsourcing their R&D and other biotech services.

11

Thank you

12